Harbour Investments, Inc. Veracyte, Inc. Transaction History

Harbour Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$18.86 - $23.55 $1,131 - $1,413	-60 Reduced 49.59%	61 $1,000
Q2 2022 Aug 15, 2022	SELL	$15.45 - $29.52 $3,167 - $6,051	-205 Reduced 62.88%	121 $2,000
Q2 2021 Aug 16, 2021	SELL	$32.94 - $56.62 $13,208 - $22,704	-401 Reduced 55.16%	326 $13,000
Q1 2021 Aug 17, 2021	BUY	$44.47 - $81.38 $32,329 - $59,163	727 New	727 $39,000

272

78.6M

42.3K

18.2K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.61B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.